CABALETTA BIO, INC. (CABA): Price and Financial Metrics

CABALETTA BIO, INC. (CABA): $1.63

0.03 (+1.87%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CABA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#292 of 304

in industry

CABA Price/Volume Stats

Current price $1.63 52-week high $8.77
Prev. close $1.60 52-week low $0.99
Day low $1.56 Volume 930,400
Day high $1.63 Avg. volume 1,618,338
50-day MA $1.68 Dividend yield N/A
200-day MA $2.51 Market Cap 82.71M

CABA Stock Price Chart Interactive Chart >


CABALETTA BIO, INC. (CABA) Company Bio


Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.


CABA Latest News Stream


Event/Time News Detail
Loading, please wait...

CABA Latest Social Stream


Loading social stream, please wait...

View Full CABA Social Stream

CABA Price Returns

1-mo -34.27%
3-mo 42.36%
6-mo -39.41%
1-year -76.88%
3-year 13.19%
5-year -85.46%
YTD -28.19%
2024 -90.00%
2023 145.41%
2022 144.06%
2021 -69.63%
2020 -10.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!